rehabilitation after lung transplantation - jivd · tx healthy 0 25 50 75 100 125 150 175 200 225...
TRANSCRIPT
Outline
• What are the challenges
• Is post LTX rehab needed • How to do rehabilita:on post LTX
• Exercise training
• Other disciplines
• Points of a?en:on
The transplanta:on: impact on func:onal status
0 10 20 30 40
50
60
70
80
QF %pred
0
10
20
30
40
50
60
70
FEV1 %pred
0 50
100 150 200
250
300
350
400
6MWD m
Mauri Am J Transplant 2008
Mauri Am J Transplant 2008
0 10 20 30 40-100
-75
-50
-25
0
25
ICU-stay (days)
Δ Q
F Po
st-P
re L
TX(N
m)
The transplanta:on: impact on func:onal status
0 50 100 150 200 250 300 350
0
4 6 8
10
12 14
Work Rate (WaLs)
Serum [La+] (mmol.L-‐1)
VO2peak ml.min-‐1.kg-‐1
LT ml.min-‐1.kg-‐1 VE l.min-‐1 MVV l.min-‐1
18.7 8.3 64 92
1.5 0.7 7.1 10
± ± ± ±
36.9 16.7 119 136
2.4 1.2 13 5
± ± ± ±
LTX (n=7) Ctr (n=7)
Muscle func:on aCer LTX
Wang AJRCCM 1999
0 50 100 150 200 250 300 350
0
4 6 8
10
12 14
Work Rate (WaLs)
0%
20%
40%
60%
80%
100%
LTX Healthy
Type II
Type I
Serum [La+] (mmol.L-‐1)
Wang AJRCCM 1999
Muscle dysfunc]on much like that seen in chronic disease Oxida]ve capacity specifically impaired
Muscle func:on aCer LTX
Post LTX (n=12) Controls (n=12) Time post TX months 35 ± 28 -‐ FEV1 %pred 74 ± 24 108 ± 12 BMI Kg.m-‐2 22 ± 2.7 24 ± 3.4 VO2peak %pred 63 ± 20 101 ± 16 Endurance min 20 ± 10 36 ± 19
Guerrero Am J Physiol Regul Integr Comp Physiol 2005
Func:onal consequences
Mechanisms of muscle dysfunc:on
Inac:vity Exacerba:ons Systemic inflamma:on Hypoxia Oxyda:ve stress Malnutri:on
Immobility & ICU Ini:a:on Immune suppression Reduced anabolism
Physical ac:vity ? Rejec:on Chronic disease
Pre-‐LTX
1yPost-‐LTX
Healthy
0100020003000400050006000700080009000
Daily Steps
Pre-‐LTX
1yPost-‐LTX
Healthy
0255075
100125150175200225
Minutes > 2 M
ETs
35% 28%
63% 52%
Langer et al. JHLTX, 2009
Mechanisms of muscle dysfunc:on
0 10 20 30 40 50 60 70 80 90 100
<1yr 1-‐5yrs
Prevalen
ce %
Hertz J Heart and lung Transplanta]on 2002.
Other long term complica:ons
Petrucci Eur J Heart Failure 2007.
0 10 20 30 40 50 60 70 80 90
100
Employed Drives car Drives motorcycle
Bicycle Infec:on previous month
Heart n=79 Lung n=72
%
Other long term complica:ons
Outline
• What are the challenges
• Pa:ents start with muscle weakness
• Pa:ents remain decondi:oned
• Long term ‘systemic consequences’
• Social problems
Outline
• What are the challenges
• Is post LTX rehab needed • How to do rehabilita:on post LTX
• Exercise training
• Other disciplines
• Points of a?en:on
A Randomized controlled trial
Both groups:
● Regular measurements of daily physical ac:vity
● Feedback on daily ac:vi:es + goal segng
Pre-LTX 160 days
Control
Exercise Training
Post-LTX 28 days
3mPost Random
12mPost Random
Resistance exercises Cycling
Treadmill walking
Stair climbing / Step
Arm Ergometry
A Randomized controlled trial
Lung transplantations performed from November
2006 until October 2009 (n=145)
Analysed (n=18)
Lost to follow-up due to severe medical complications (n=3)
Allocated to intervention group (n=21) Received allocated intervention (n=21)
Lost to follow-up due to severe medical complications (n=2) or unwillingness to continue participation in the study (n=1)
Allocated to control group (n=19) Received allocated intervention (n=19)
Analysed (n=16)
Allocation
Analysis
Follow-Up
Enrollment
Randomized (n=40)
Excluded (n=105) ● Not meeting inclusion criteria (n=72)
● < 40 yrs (n=53) ● > 6 wks hospital stay (n=19)
● Declined to participate (n=33)
Interven:on Control Age (yrs) 59 ± 4 59 ± 6
Height (cm) 165 ± 7 166 ± 7
Weight (kg) 61 ± 15 58 ± 13
Gender (m/f) 9 / 9 7 / 9
Time to LTX (days) 174 ± 118 152 ± 154
Hospital stay (days) 27 ± 7 28 ± 7
COPD (%) 15 (83%) 14 (88%)
SSLTX (%) 15 (83%) 14 (88%)
Acute Rejec:on (%) 6 (33%) 5 (31%)
Baseline Characteris:cs
Pre Post
3mPost
1yPost
20
40
60
80
100
TrainingControl
Walking (m
in/day)
Pre Post
3mPost
1yPost
0
25
50
75
100
125
>3METs PA
(min/day)
P = 0.06
*
*
*
= Interven:on period
*
*
*
Physical ac:vity
Pre Post
3mPost
1yPost
40
50
60
70
80
90
100 **
QF %pred
Pre Post
3mPost
1yPost
40
50
60
70
80
90
100
TrainingControl
**
6MWD %pred
* = p<0.05
Physical fitness
Interven:on Control p BMI (kg/m2)
Pre-‐LTX
1yPostLTX
22.6
24.4
±
±
4.6
4.7
21.5
24.1
±
±
4.9
4.0
0.89
BP systolic (mmHg)
Pre-‐LTX
1yPost-‐LTX
129
126
±
±
13
8
126
142
±
±
12
16
0.00
Diabetes (%)
Pre-‐LTX
1yPostLTX
-‐
1
(6%)
-‐
4
(25%)
0.11
Co-‐morbidity
Outline
• What are the challenges
• Is post LTX rehab needed • Pulmonary rehabilita:on is essen:al to restore exercise tolerance and Physical Ac:vity
• It may prevent long term systemic consequences
• Should be part of the management of pa:ents post LTX
Outline
• What are the challenges
• Is post LTX rehab needed • How to do rehabilita:on post LTX
• Exercise training
• Other disciplines
• Points of a?en:on
How to conduct exercise training post LTX
• General training principles apply • Intensity • Dura:on • Frequency • Specificty
• Focus on restoring muscle func:on • Include resistance training
• A?en:on for balance and propriocep:on as these pa:ents may start moving again...
How to conduct Rehab post LTX
• A?en:on for • Social aspects and psychological aspects • Compliance and relapse of old behavior • Reïntegra:on, work
No smokers Ac]ve smoking Posi]ve Co]nin
Vos Eur Respir J 2010
Outline
• What are the challenges
• Is post LTX rehab needed • How to do rehabilita:on post LTX
• Exercise training
• Other disciplines
• Points of a?en:on
Factors further complica:ng post TX exercise performance
• Gender
Pre LT
X
Post LT
X
Post Reha
0
100
200
300
400
500
600
6MW
D (m
)
Pre LT
X
Post LT
X
Post Reha
30
40
50
60
70
80
90
QF
(% p
red)
Mauri Am J Transplant 2008
Male Female
• Osteoporosis
Maalouf, J Clin Endocrinol Metab 2005
Factors further complica:ng post TX exercise performance
0,8
0,85
0,9
0,95
1
1,05
1,1
1,15
Pre LTX Post 2months Post 8months
Control (n=10)
Alendronate (n = 10)
Alendronate + training (n = 10)
Δ in lumbar v
ertebral BMD (L-‐2 and
L-‐3) %pre
Braith J Heart Lung Transplantation 2006
Factors further complica:ng post TX exercise performance
• Tendinopathy
Chhajed, Eur Respir J 2002
No
Tendini]s
Rupture
2.2±2.7 years post LTX Risk factors Underlying Emphysema (p=0.07) Use of fluoroquinolones 20/22 cases
Factors further complica:ng post TX exercise performance